US Stock MarketDetailed Quotes

INKT MiNK Therapeutics

Watchlist
  • 0.776
  • +0.012+1.55%
Close Sep 13 16:00 ET
  • 0.776
  • 0.0000.00%
Post 20:02 ET
30.66MMarket Cap-1615P/E (TTM)

MiNK Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

MiNK Therapeutics Q2 2024 Earnings Date

Currency：USDAug 13, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
0
0
0
--
--
--
EPS
-0.09
-0.07
+0.02
Beat Est.
+50.03%
+61.11%
+22.14%
Analyst Rating
Buy

Sep 15, 2024

MiNK Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q3-- / 0.000--
Aug 13, 20242024/Q20.000 / 0.000--
May 14, 20242024/Q10.000 / 0.000--
Mar 21, 20242023/Q40.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q3-- / 0.000--
Aug 13, 20242024/Q20.000 / 0.000--
May 14, 20242024/Q10.000 / 0.000--
Mar 21, 20242023/Q40.000 / 0.000--

Unlock Free Earnings Estimates

MiNK Therapeutics Earnings Reports

  • MiNK Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 13 16:11 ET

  • MiNK Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 14 07:29 ET

  • MiNK Therapeutics | 10-K: FY2023 Annual Report

    Mar 21 16:07 ET

  • MiNK Therapeutics | 10-Q: Q3 2023 Earnings Report

    Nov 14, 2023 17:17 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Sep 15, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data